As with insulin therapies, patient education on proper injection technique and storage is essential
Discussion PCCA or PCCB mutations result in impaired propionyl-CoA catabolism and various complications in patients with PA
Abstract Background Many branches of biomedical research find use for pure recombinant proteins for direct application or to study other molecules and pathways
A specific L-glutamine pharmaceutical formulation has been approved by regulatory authorities for sickle cell disease management, which is distinct from dietary supplement uses
Oral formulations overcome barriers associated with injectable drugs, offering greater convenience and acceptance among patients who are reluctant or unable to use injections
CNS Drug Reviews 12:250275 Bowles D, Isayenkova J, Lim EK, Poppenberger B (2005) Glycosyltransferases: managers of small molecules